Compared to the opening price on Wednesday 09/11/ on BTT of $, this is a gain of %. Beam Therapeutics Inc Registered Shs's market capitalization is. Beam Therapeutics is traded on the NASDAQ Global Market under the ticker symbol BEAM. Who is Beam Therapeutics' transfer agent? Computershare Trust Company. View the BEAM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Beam Therapeutics Inc. Stock analysis for Beam Therapeutics Inc (BEAM:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. Discover real-time Beam Therapeutics Inc. Common Stock (BEAM) stock prices, quotes, historical data, news, and Insights for informed trading and investment.
What ETF is Beam Therapeutics, Inc. in? Information about cost, fund size and performance of the ETFs that contain this stock. BEAM - Beam Therapeutics Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS). Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Stock Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the. Latest Beam Therapeutics Inc (BEAM:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Beam Therapeutics (BEAM) delivered earnings and revenue surprises of % and %, respectively, for the quarter ended June Stock Quote. Common Stock. BEAM. Price. $ Change (%). + (+%). Volume. , Data as of 09/11/24 PM EDT. Refreshes every 15 minutes. Data. Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. Beam Therapeutics (BEAM) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. The company is headquartered in Cambridge.
Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which. Beam Therapeutics Inc. · · Partner Center · Your Watchlists · Recently Viewed Tickers · BEAM Overview · Key Data · Performance · Analyst Ratings. Sell. Beam Therapeutics Inc. ; Open. $ Previous Close$ ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - About Beam Therapeutics Inc Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision. Beam Therapeutics Inc BEAM:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date02/27/24 · 52 Week Low. Research Beam Therapeutics' (Nasdaq:BEAM) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. BEAM will report The current price of BEAM is USD — it has increased by % in the past 24 hours. Watch Beam Therapeutics Inc. stock price performance more closely on. Get the latest Beam Therapeutics Inc (BEAM) real-time quote, historical performance, charts, and other financial information to help you make more informed.
Press Releases · August 6, Beam Therapeutics Reports Pipeline Updates and Second Quarter Financial Results · July 15, Beam Therapeutics Announces. In the current month, BEAM has received 7 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. BEAM average Analyst price target in the past 3 months is $ Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. Get the latest Beam Therapeutics Inc. (BEAM) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. The stock price for Beam Therapeutics (NASDAQ: BEAM) is $ last updated September 11, at PM EDT. Q. Does Beam Therapeutics (BEAM).
Beam Therapeutics Stock $BEAM: Patents and Partners
Based on short-term price targets offered by 12 analysts, the average price target for Beam Therapeutics Inc. comes to $ The forecasts range from a low of.